Fig. 6From: Transcriptional alterations of protein coding and noncoding RNAs in triple negative breast cancer in response to DNA methyltransferases inhibitionLong non-coding RNA (lncRNA) transcriptome in MDA-MB-231 and BT-549 TNBC cells treated with DNMT inhibitors. a Hierarchical clustering of MDA-MB-231 and BT-549 TNBC cells treated with Decitabine, 5-Azacytidine, or DMSO control based on differentially expressed lncRNA transcripts between the two groups. Each column represents one sample and each row represents a transcript. Expression level of each lncRNA (log2) in a single sample is depicted according to the color scale. b Principal component analysis (PCA) for MDA-MB-231 and BT-549 TNBC cells treated with Decitabine, 5-Azacytidine, or DMSO control based on lncRNA transcriptomeBack to article page